Cencora stock enters fiscal 2027 with stronger earnings outlook
Published on 11/07/2026 at 10:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCencora enters fiscal 2027
- Fiscal fourth-quarter revenue rose 5.5 percent to 88.4 billion US dollars.
- Management expects adjusted diluted earnings per share of 19.40 to 19.75 US dollars in fiscal 2027.
- The quarterly dividend will rise 10 percent to 0.66 US dollars per share.
Cencora reported stronger fiscal fourth-quarter results on Wednesday, November 4, and set an adjusted earnings outlook for fiscal 2027 that points to continued growth. The company also announced a higher quarterly dividend, giving investors two key updates as the new fiscal year begins.
According to the company’s November 4 earnings release, fourth-quarter revenue increased 5.5 percent to 88.4 billion US dollars. GAAP diluted earnings per share came to 2.71 US dollars, while adjusted diluted earnings per share rose 21.4 percent to 4.66 US dollars.
Higher earnings outlook for fiscal 2027
Cencora expects fiscal 2027 revenue to grow 3 percent to 5 percent. Adjusted operating income is expected to increase 4 percent to 6 percent, while adjusted diluted earnings per share is forecast at 19.40 to 19.75 US dollars, compared with 17.97 US dollars in fiscal 2026.
The company is changing its reporting structure for fiscal 2027. Pharmaceutical Distribution and Services will be separated from Specialty Pharmaceutical and Provider Services, allowing investors to assess the faster-growing specialty activities more directly. Cencora expects specialty segment operating income to rise 18 percent to 21 percent in fiscal 2027.
Dividend points to shareholder returns
On November 3, Cencora declared a quarterly dividend of 0.66 US dollars per common share, up from 0.60 US dollars. The payment is scheduled for November 30 to shareholders of record at the close of business on November 13.
The earnings release also highlighted adjusted fiscal 2026 operating income of 4.8 billion US dollars and adjusted diluted earnings per share of 17.97 US dollars. Investors will now focus on whether the new segment structure and specialty growth targets translate into sustained earnings momentum.
The real-time quote of Cencora stock showed the shares at 299.30 euros on Lang & Schwarz at 10:56 CET on Saturday, November 7.
Cencora Inc. key facts
- Company: Cencora Inc.
- ISIN: US03073E1055
- NYSE ticker: COR
- Fiscal fourth-quarter revenue: 88.4 billion US dollars for the quarter ended September 30, 2026
- Fiscal 2027 adjusted EPS outlook: 19.40 to 19.75 US dollars per share
- Quarterly dividend: 0.66 US dollars per share, payable November 30, 2026
The broader U.S. market context is covered in current S&P 500 market reports.
